ORLANDO, FL / ACCESS Newswire / June 6, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc.

Opioid use continues to be a significant problem felt broadly in our community,” a city officials told the City Council this ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Eton Pharmaceuticals is experiencing explosive rare-disease revenue growth, with a 117% YoY increase and a robust pipeline ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance generating revenues with ensuring that a new medicine reaches the largest possible ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...

Tonix Pharmaceuticals Holding Corp.'s TNX-102 SL faces an FDA decision by August 2025. Click here to read an analysis of TNXP ...

Eight Philadelphia-area companies made this year’s Fortune 500 list, which ranks the country’s largest businesses by revenue.

Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact ...